Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian CohortArturo Ciccullo, Simona Di Giambenedetto, Alessandra Latini et al.|Viruses|2022Cited by 12
TD-9 Exploring the use of darunavir boosted plus dolutegravir in highly treatment-experienced HIV population: a retrospective Cohort studyAndrea De Vito, Antonio Di Biagio, Gisele Pedroso Moi et al.|Unknown|2024Cited by 0